Related Experiment Video
Updated: Sep 27, 2026

Anesthesia-free Heartbeat Measurements in Freely Moving Zebrafish
Published on: April 18, 2025
An Anesthesia-Free Pharmacological Assay for Zebrafish Heart Failure Models Using a Microfluidic Platform
Qiuyue Song1, Fangrui Liu2, Jinyan Zhao1
1Research Institute of Marine Traditional Chinese Medicine (Qingdao Academy of Chinese Medical Sciences), The SATCM's Key Unit of Discovering and Developing New Marine TCM Drugs, Key Laboratory of Marine Traditional Chinese Medicine in Shandong Universities, Shandong University of Traditional Chinese Medicine, Qingdao 266114, China.
Abstract:
Background: The zebrafish model is extensively utilized for phenotypic screening, particularly in heart failure research. However, traditional photography-based data collection requires tricaine methanesulfonate (MS-222) anesthesia, which can suppress cardiac function and introduce artifacts. This study presents a microfluidic platform designed to facilitate anesthesia-free, noninvasive in vivo photography of zebrafish heart failure models. Methods: Isoproterenol (ISO) induced heart failure in 1 day post-fertilization (dpf) zebrafish embryos. Larvae were assigned to three groups: Control (E3 embryo medium only), Model (1 mM ISO for 48 h from 1 dpf), and Positive (1 mM ISO + 10 μM propranolol for 48 h from 1 dpf). Subsequently, a microfluidic chip featuring tapered immobilization channels was adopted. The chip facilitated the photography and collection of cardiac function parameters from lateral and supine positions, including cardiac output (CO), blood flow velocity (BFV), ejection fraction (EF), stroke volume (SV), and fractional shortening (FS). All imaging was performed in completely independent parallel experiments, with no individual larva shared between the two imaging methods. Data obtained under hydrodynamic confinement were compared with those acquired under MS-222 anesthesia. Results: Cardiac parameters measured using the microfluidic platform were significantly higher than those under MS-222 anesthesia: CO (0.339 ± 0.032 vs. 0.279 ± 0.023 nL/s, p < 0.001), BFV (681 ± 53 vs. 604 ± 38 μm/s, p < 0.001), EF (10.3 ± 0.7% vs. 6.6 ± 0.7%, p < 0.001), SV (184,519 ± 12,822 vs. 97,979 ± 5306 μm3, p < 0.001), and FS (7.3 ± 1.8% vs. 3.7 ± 0.9%, p < 0.001). Strong correlations (R2 > 0.85, p < 0.0001) revealed that anesthesia underestimated parameters by 11.3-49.3%. Conclusions: Compared with the traditional anesthesia-based method, the microfluidic platform enables more precise cardiac parameter collection in a zebrafish heart failure model than when anesthesia is used, offering a reliable tool for phenotypic screening of zebrafish embryos.

